Onyx Announcement???, page-30

No one cares about cash backing. Loads of money will be required going forward. What investors care about is progress. PAB were able to announce the initiation of trials with Onyx to a lot of fanfare and a subsequent $12.5mill rights placement announcement 2 days later in November last year, but 9 months on and its all highly secretive confidential hush hush. Can't have it both ways. Bottom line is there is a long way to go for this company to produce anything of IP value to shareholders and there will be a lot of money and shares issued in between. It's a long-term commitment and if that doesn't suit then PAB is probably not the company for your investment style. As always with these types of companies in the bio sector your best guide is share price action. Inside information rules.